IBXXF Stock - Imagion Biosystems Limited
Unlock GoAI Insights for IBXXF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.67M | $4.97M | $3.07M | $2.86M | $205,717 |
| Gross Profit | $2.26M | $-279,835 | $-544,926 | $151,534 | $-2,655,055 |
| Gross Margin | 85.0% | -5.6% | -17.7% | 5.3% | -1290.6% |
| Operating Income | $-756,553 | $-15,814,286 | $-12,139,137 | $-8,314,521 | $-7,759,070 |
| Net Income | $-2,066,957 | $-12,473,916 | $-9,809,193 | $-6,024,706 | $-5,364,007 |
| Net Margin | -77.6% | -250.9% | -319.4% | -211.0% | -2607.5% |
| EPS | $-0.05 | $-0.41 | $-0.35 | $-0.23 | $-0.29 |
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
Visit WebsiteEarnings History & Surprises
IBXXFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 26, 2026 | — | — | — | — |
Q3 2025 | Sep 1, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 30, 2025 | — | — | — | — |
Q1 2025 | Mar 24, 2025 | — | $-0.01 | — | — |
Q4 2024 | Oct 28, 2024 | — | — | — | — |
Q3 2024 | Aug 30, 2024 | — | $-0.03 | — | — |
Q2 2024 | Apr 30, 2024 | — | — | — | — |
Q1 2024 | Feb 29, 2024 | — | $-0.10 | — | — |
Q1 2024 | Jan 30, 2024 | — | — | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.18 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.09 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.10 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.05 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.14 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.08 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.13 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.06 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.04 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.06 | — | — |
Latest News
Frequently Asked Questions about IBXXF
What is IBXXF's current stock price?
What is the analyst price target for IBXXF?
What sector is Imagion Biosystems Limited in?
What is IBXXF's market cap?
Does IBXXF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to IBXXF for comparison